Pioglitazone reduces cardiovascular events and dementia but increases bone fracture in elderly patients with type 2 diabetes mellitus: a national cohort study

Chieh-Li Yen; Chao-Yi Wu; Chung-Ying Tsai; Cheng-Chia Lee; Yi-Jung Li; Wei-Sheng Peng; Jia-Rou Liu; Yuan-Chang Liu; Chang-Chyi Jenq; Huang-Yu Yang; Lai-Chu See

doi:doi:10.18632/aging.204643

← Back

Research Paper Volume 15, Issue 7 pp 2721—2733

Pioglitazone reduces cardiovascular events and dementia but increases bone fracture in elderly patients with type 2 diabetes mellitus: a national cohort study

Figure 2. Cumulative incidence for varied major advanced cardiac and cardiovascular events (MACCE) after propensity score stabilizing weighting. (A) Coronary artery bypass graft (CABG), (B) Myocardial infarction (MI), (C) Percutaneous coronary intervention (PCI), (D) stroke, (E) MACCE-related death, (F) overall MACCE.